Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
4.260
-0.140 (-3.18%)
Apr 29, 2026, 10:21 AM EDT - Market open
Larimar Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 85.41 | 33.22 | 26.75 | 26.83 | 70.1 | Upgrade
|
| Short-Term Investments | 51.44 | 150.24 | 60.04 | 91.6 | - | Upgrade
|
| Cash & Short-Term Investments | 136.85 | 183.45 | 86.79 | 118.43 | 70.1 | Upgrade
|
| Cash Growth | -25.40% | 111.38% | -26.71% | 68.95% | -24.33% | Upgrade
|
| Other Receivables | 0.75 | 1.05 | 0.33 | - | 0.21 | Upgrade
|
| Receivables | 0.75 | 1.05 | 0.33 | - | 0.21 | Upgrade
|
| Prepaid Expenses | 4.42 | 10.8 | 3.05 | 2.31 | 1.9 | Upgrade
|
| Total Current Assets | 142.02 | 195.3 | 90.18 | 120.74 | 72.2 | Upgrade
|
| Property, Plant & Equipment | 2.69 | 3.72 | 3.76 | 3.69 | 4.46 | Upgrade
|
| Other Long-Term Assets | 1.13 | 1.2 | 2 | 1.98 | 2.01 | Upgrade
|
| Total Assets | 145.84 | 200.23 | 95.94 | 126.41 | 78.67 | Upgrade
|
| Accounts Payable | 5.22 | 2.42 | 1.28 | 1.69 | 1.66 | Upgrade
|
| Accrued Expenses | 58.47 | 20.87 | 7.39 | 8.41 | 6.59 | Upgrade
|
| Current Portion of Leases | 1.11 | 1.06 | 0.84 | 0.61 | 0.59 | Upgrade
|
| Total Current Liabilities | 64.8 | 24.36 | 9.51 | 10.71 | 8.85 | Upgrade
|
| Long-Term Leases | 2.96 | 4.06 | 4.71 | 4.8 | 5.41 | Upgrade
|
| Total Liabilities | 67.76 | 28.41 | 14.22 | 15.5 | 14.25 | Upgrade
|
| Common Stock | 0.08 | 0.06 | 0.04 | 0.04 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 512.78 | 440.76 | 270.15 | 262.5 | 180.65 | Upgrade
|
| Retained Earnings | -434.83 | -269.16 | -188.55 | -151.61 | -116.25 | Upgrade
|
| Comprehensive Income & Other | 0.05 | 0.15 | 0.08 | -0.03 | - | Upgrade
|
| Shareholders' Equity | 78.09 | 171.81 | 81.72 | 110.9 | 64.41 | Upgrade
|
| Total Liabilities & Equity | 145.84 | 200.23 | 95.94 | 126.41 | 78.67 | Upgrade
|
| Total Debt | 4.07 | 5.12 | 5.55 | 5.41 | 6 | Upgrade
|
| Net Cash (Debt) | 132.79 | 178.34 | 81.24 | 113.02 | 64.1 | Upgrade
|
| Net Cash Growth | -25.54% | 119.51% | -28.12% | 76.33% | -25.58% | Upgrade
|
| Net Cash Per Share | 1.82 | 2.91 | 1.85 | 4.39 | 3.73 | Upgrade
|
| Filing Date Shares Outstanding | 103.88 | 64.03 | 63.8 | 43.27 | 17.71 | Upgrade
|
| Total Common Shares Outstanding | 83.09 | 63.82 | 43.91 | 43.27 | 17.71 | Upgrade
|
| Working Capital | 77.23 | 170.95 | 80.67 | 110.03 | 63.36 | Upgrade
|
| Book Value Per Share | 0.94 | 2.69 | 1.86 | 2.56 | 3.64 | Upgrade
|
| Tangible Book Value | 78.09 | 171.81 | 81.72 | 110.9 | 64.41 | Upgrade
|
| Tangible Book Value Per Share | 0.94 | 2.69 | 1.86 | 2.56 | 3.64 | Upgrade
|
| Machinery | 2.42 | 2.38 | 1.86 | 1.71 | 1.61 | Upgrade
|
| Leasehold Improvements | 0.09 | 0.05 | 0.05 | 0.03 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.